MannKind Corp (NASDAQ:MNKD)

Biotechnology word cloud

Biotech Short Interest Becomes Stock Specific (Updated)

The short interest data are out for the October 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Intel logo

The 5 Most-Heavily Shorted Nasdaq Stocks

Surges in short interest in Intel and Comcast between the October 15 and October 31 settlement dates made sure they remained near the top of the list of most shorted ...
Read Full Story »
462542665

MannKind Spending Trends See Improvements

MannKind Corp. (NASDAQ: MNKD) reported its third-quarter financial results on Monday morning. 24/7 Wall St. was not expecting any major insight or inflection point from this report because it is ...
Read Full Story »
Biotechnology word cloud

Biotech Short Interest Becomes Stock Specific

The short interest data are out for the October 15, settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
health care

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

There had been some brief hopes that the worst was over for struggling MannKind Corp. (NASDAQ: MNKD). It turns out that not all great FDA approvals end up being great ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More

Stocks were lower on Monday morning after IBM issued a spoiler alert on its earnings report. Last week's bounce has shown again that investors still are willing to keep buying ...
Read Full Story »
Biotechnology word cloud

Short Interest in Biotech Becomes Company Specific

The short interest data are out for the end of September settlement date. Biotech companies are considered a riskier group of stocks with big upside and big downside. FDA rulings ...
Read Full Story »
Apple Watch intro

Apple Slips From 5 Most Shorted Nasdaq Stocks

In the wake of the successful launch of the new iPhones, short sellers got out of the way of Apple. Its short interest plunged nearly 30% between the September 15 ...
Read Full Story »
research

Short Sellers Make Moves in Key Biotech Stocks

The short interest report is out for the September 15 settlement date, and here 247 Wall St. has decided to focus on the biotech sector. Short sellers are often active ...
Read Full Story »
Biotechnology word cloud

Short Sellers Remain Vigilant Against Biotechs

The short interest report is out for the August 29 settlement date, and 24/7 Wall St. is focusing on the biotech sector. Short sellers are often active in biotech stocks, ...
Read Full Story »
biotech

Rising Short Interest in Biotech Stocks

The short interest data is out for the August 15 settlement date. Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts, ...
Read Full Story »
Stock Split Image

What the Market is Telling MannKind (Updated)

MannKind Corp. (NASDAQ: MNKD) was supposed to be a huge winner on this week's news that Sanofi (NYSE: SNY) will become its global partner for its inhalable insulin Afrezza. There has ...
Read Full Story »
76764023

MannKind Secures Future of Afrezza in Major Sanofi Deal

MannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of its strategy on how to get its Afrezza inhalable insulin ...
Read Full Story »
buy sell

Thirteen Analyst Stocks Under $10 With Huge Upside Potential

Stocks hit a new all-time this last week on the heels of a strong unemployment and jobs number. Now investors have to decide whether the next year or more will ...
Read Full Story »
MannKind Poll smaller

MannKind Poll Points to Bias That Stock Will Rise Above $15 into 2015

MannKind Corp. (NASDAQ: MNKD) has dipped back under $10 in the wake of the FDA finally giving approval for its Afrezza as inhalable insulin for diabetic patients. The move may ...
Read Full Story »